Department of Medicine, Kettering Medical Center, Dayton, Ohio.
Department of Medicine, Kettering Medical Center, Dayton, Ohio; Department of Medicine, Boonshoft School of Medicine Wright State University, Dayton, Ohio; Renal Physicians Inc., Dayton, Ohio.
Am J Med Sci. 2021 Apr;361(4):517-521. doi: 10.1016/j.amjms.2020.10.005. Epub 2020 Oct 7.
A 73-year-old Caucasian female with a history of obesity status post Roux-en-Y gastric bypass (RYGB) surgery presented with generalized weakness and was found to have acute kidney injury (AKI) with a creatinine peak of 9.1 mg/dL above her baseline of 1.2 mg/dL, and anemia with hemoglobin 5.7 g/dl. Kidney biopsy revealed oxalate nephropathy likely related to gastric bypass surgery four years prior. RYGB is a strong risk factor for hyperoxaluria, nephrolithiasis, and oxalate nephropathy which often progresses to end-stage renal disease (ESRD). Meaningful treatment strategies for this disease entity are lacking. We present a case in which dietary and pharmacological management without the use of renal replacement therapy resulted in stabilization of chronic kidney disease (CKD) stage 5 for seven years at the time of this writing.
一位 73 岁的白人女性,既往有肥胖病史,曾接受过 Roux-en-Y 胃旁路手术(RYGB),因全身乏力就诊,发现急性肾损伤(AKI),血肌酐峰值较基线值 1.2mg/dL 升高 9.1mg/dL,同时伴有贫血,血红蛋白为 5.7g/dl。肾活检提示草酸钙肾病,可能与四年前文胃旁路手术有关。RYGB 是高草酸尿症、肾结石和草酸钙肾病的强烈危险因素,这些疾病通常会进展为终末期肾病(ESRD)。目前缺乏针对这种疾病实体的有效治疗策略。我们报告了一例病例,该患者在未使用肾脏替代治疗的情况下,通过饮食和药物治疗,在本报告撰写时,慢性肾脏病(CKD)5 期已稳定 7 年。